Combos, New MOAs, And Oral Formulations Of Injectables: Lilly’s Immunology Strategy
In a competitive immunology landscape, Eli Lilly is looking for novel agents, oral formulations of injectables, and combination therapies that can optimize response and expand the patient pool.